CSHL1 | Chorionic somatomammotropin hormone-like 1 | Predicted secreted proteins
| | ![](/images/25646/if_selected_60x60.jpg) | ![](/images/25646/ihc_cell_selected_60x60.jpg) | ![](/images/25646/59005_A_1_8_rna_selected_60x60.jpg) | Tissue enriched |
PSG11 | Pregnancy specific beta-1-glycoprotein 11 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42240/91488_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
KISS1 | KiSS-1 metastasis-suppressor | Cancer-related genes Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17775/140624_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
CSH1 | Chorionic somatomammotropin hormone 1 (placental lactogen) | Predicted secreted proteins
| | ![](/images/26374/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26374/58390_A_2_6_rna_selected_60x60.jpg) | Tissue enriched |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38934/101362_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
CGB | Chorionic gonadotropin, beta polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images/38934/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38934/101362_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
ISM2 | Isthmin 2 | Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/39314/142436_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
CGB1 | Chorionic gonadotropin, beta polypeptide 1 | Predicted secreted proteins
| | ![](/images/38934/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38934/101362_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
XAGE2 | X antigen family, member 2 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60900/139283_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
XAGE2B | X antigen family, member 2B | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52507/135040_B_9_5_rna_selected_60x60.jpg) | Tissue enriched |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images/1667/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16724/37572_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/51194/ihc_cell_selected_60x60.jpg) | ![](/images/355/2188_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
PLAC1 | Placenta-specific 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63425/141570_A_3_5_rna_selected_60x60.jpg) | Tissue enriched |
PAPPA2 | Pappalysin 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18412/144215_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes
| | ![](/images_static/na_center.gif) | | ![](/images/3336/9545_B_9_2_rna_selected_60x60.jpg) | Group enriched |
ALPP | Alkaline phosphatase, placental | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26327/101288_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/30866/72417_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43261/103681_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
TFPI2 | Tissue factor pathway inhibitor 2 | Predicted secreted proteins
| | ![](/images/54479/if_selected_60x60.jpg) | | ![](/images/10142/25846_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
SIGLEC6 | Sialic acid binding Ig-like lectin 6 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18198/148851_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
HSD17B1 | Hydroxysteroid (17-beta) dehydrogenase 1 | Enzymes
| | | ![](/images_static/rna_center.gif) | ![](/images/21032/48795_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23350/53827_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38934/101362_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45402/119108_B_7_2_rna_selected_60x60.jpg) | Tissue enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | ![](/images_static/rna_center.gif) | ![](/images/4003/141639_A_2_1_rna_selected_60x60.jpg) | Group enriched |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images/26401/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12853/30163_A_3_5_rna_selected_60x60.jpg) | Tissue enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | ![](/images/5872/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/5872/140607_B_1_6_rna_selected_60x60.jpg) | Group enriched |
PAEP | Progestagen-associated endometrial protein | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/20108/ihc_cell_selected_60x60.jpg) | ![](/images/20108/151397_B_7_4_rna_selected_60x60.jpg) | Group enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62273/149779_A_1_2_rna_selected_60x60.jpg) | Group enriched |
LIN28B | Lin-28 homolog B (C. elegans) | | | | ![](/images_static/rna_center.gif) | ![](/images/36630/140610_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53254/146500_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CHAT | Choline O-acetyltransferase | Disease related genes Enzymes Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images/48547/ihc_cell_selected_60x60.jpg) | ![](/images/2313/5937_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2593/10111_B_8_7_rna_selected_60x60.jpg) | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | ![](/images/31032/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31033/72999_A_3_5_rna_selected_60x60.jpg) | Group enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11740/142514_A_3_3_rna_selected_60x60.jpg) | Tissue enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13819/30339_B_2_3_rna_selected_60x60.jpg) | Tissue enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33689/80801_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16436/142443_B_8_5_rna_selected_60x60.jpg) | Group enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/44165/102041_B_8_8_rna_selected_60x60.jpg) | Group enriched |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2981/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2981/8435_B_7_8_rna_selected_60x60.jpg) | Group enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/52887/143241_B_7_4_rna_selected_60x60.jpg) | Group enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46972/146495_B_7_7_rna_selected_60x60.jpg) | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15480/35524_A_4_6_rna_selected_60x60.jpg) | Group enriched |
WNT2 | Wingless-type MMTV integration site family member 2 | Cancer-related genes Predicted secreted proteins
| | ![](/images/20920/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/20920/47842_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/5963/137904_B_8_5_rna_selected_60x60.jpg) | Group enriched |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7796/18530_A_9_5_rna_selected_60x60.jpg) | Tissue enriched |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/40232/139275_B_7_2_rna_selected_60x60.jpg) | Tissue enriched |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | ![](/images/6279/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/6279/17967_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/67972/149849_A_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20280/153432_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |